147 related articles for article (PubMed ID: 37393461)
1. Screening approaches for lung cancer by blood-based biomarkers: Challenges and opportunities.
van den Broek D; Groen HJM
Tumour Biol; 2024; 46(s1):S65-S80. PubMed ID: 37393461
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer screening: a critical appraisal.
Kian W; Zemel M; Levitas D; Alguayn W; Remilah AA; Rahman NA; Peled N
Curr Opin Oncol; 2022 Jan; 34(1):36-43. PubMed ID: 34652284
[TBL] [Abstract][Full Text] [Related]
3. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
4. Benefit-to-radiation-risk of low-dose computed tomography lung cancer screening.
Hendrick RE; Smith RA
Cancer; 2024 Jan; 130(2):216-223. PubMed ID: 37909872
[TBL] [Abstract][Full Text] [Related]
5. [Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test].
Sestini S; Boeri M; Marchianò A; Silva M; Calareso G; Galeone C; Sozzi G; Pastorino U
Epidemiol Prev; 2016; 40(1 Suppl 1):42-50. PubMed ID: 26951732
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
[TBL] [Abstract][Full Text] [Related]
7. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
[TBL] [Abstract][Full Text] [Related]
9. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
Lancaster HL; Heuvelmans MA; Oudkerk M
J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
[TBL] [Abstract][Full Text] [Related]
10. Hesitancy around low-dose CT screening for lung cancer.
Dickson JL; Horst C; Nair A; Tisi S; Prendecki R; Janes SM
Ann Oncol; 2022 Jan; 33(1):34-41. PubMed ID: 34555501
[TBL] [Abstract][Full Text] [Related]
11. CT screening for lung cancer: Are we ready to implement in Europe?
Balata H; Evison M; Sharman A; Crosbie P; Booton R
Lung Cancer; 2019 Aug; 134():25-33. PubMed ID: 31319989
[TBL] [Abstract][Full Text] [Related]
12. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
[TBL] [Abstract][Full Text] [Related]
13. Lung Cancer Screening by Low-Dose Computed Tomography - Part 1: Expected Benefits, Possible Harms, and Criteria for Eligibility and Population Targeting.
Kaaks R; Delorme S
Rofo; 2021 May; 193(5):527-536. PubMed ID: 33212540
[TBL] [Abstract][Full Text] [Related]
14. Emerging Strategies in Lung Cancer Screening: Blood and Beyond.
Bhalla S; Yi S; Gerber DE
Clin Chem; 2024 Jan; 70(1):60-67. PubMed ID: 38175587
[TBL] [Abstract][Full Text] [Related]
15. Low-dose CT for lung cancer screening: opportunities and challenges.
Shen H
Front Med; 2018 Feb; 12(1):116-121. PubMed ID: 29218678
[TBL] [Abstract][Full Text] [Related]
16. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
Carroll NM; Burnett-Hartman AN; Joyce CA; Kinnard W; Harker EJ; Hall V; Steiner JS; Blum-Barnett E; Ritzwoller DP
J Gen Intern Med; 2020 Apr; 35(4):1143-1152. PubMed ID: 31974902
[TBL] [Abstract][Full Text] [Related]
17. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
[TBL] [Abstract][Full Text] [Related]
18. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
19. The evidence for low-dose CT screening of lung cancer.
Ruchalski K; Gutierrez A; Genshaft S; Abtin F; Suh R
Clin Imaging; 2016; 40(2):288-95. PubMed ID: 26362352
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
